The challenge: Understanding key competitor’s activities in the rapidly changing oncology landscape.
A Top-10 Pharma company partnered with LucidQuest in its effort to gain an understanding of the key competitors’ activities in the breast cancer market in EU5 and Japan.
The Action: Primary and secondary research into competitor’s marketing, KOL, and salesforce plans.
LucidQuest conducted both secondary and primary intelligence to identify the competitor’s marketing and KOL engagement plans and better understand their field force status and future plans for expansion.
We interviewed leading BC KOLs across EU5 and Japan to do a deep dive into the evolving Tx paradigm in the region and estimate the likelihood of acceptance/success for our client’s asset and Dx in that space.
The Result: An optimized client’s asset launch supported by the detailed report LucidQuest prepared.
The client obtained a detailed report on the competitor’s activities that allowed them to refine their strategies, develop more effective countermeasures against competitive threats, and finally optimize their asset’s launch in the BC space both in EU5 and Japan markets.
#oncology #immunooncology #breastcancer #competitiveanalysis #druglaunch #casestudy #ourwork